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We examined the eﬀectiveness of acupuncture to reduce the severity and intensity of primary dysmenorrhea. A randomized
controlled trial compared acupuncture with control acupuncture using a placebo needle. Eligible women were aged 14–25 years
with a diagnosis of primary dysmenorrhea. Women received nine sessions of the study treatment over 3 months. The primary
outcomes were menstrual pain intensity and duration, overall improvement in dysmenorrhea symptoms and reduced need for
additional analgesia, measured at 3, 6 and 12 months from trial entry. A total of 92 women were randomly assigned to the
intervention (acupuncture n = 46 and control n = 46). At 3 months although pain outcomes were lower for women in the
acupuncture group compared with the control group, there was no signiﬁcant diﬀerence between groups. Women receiving
acupuncture reported asmallreduction inmoodchangescomparedwiththecontrolgroup, relativerisk(RR)0.72,95%conﬁdence
interval (CI) 0.53–1.00, P = .05. Follow-up at 6 months found a signiﬁcant reduction in the duration of menstrual pain in the
acupuncture group compared with the control group, mean diﬀerence –9.6, 95% CI –18.9 to –0.3, P = .04, and the need for
additional analgesia was signiﬁcantly lower in the acupuncture group compared with the control group, RR 0.69, 95% CI 0.49–
0.96, P = .03, but the follow-up at 12 months found lack of treatment eﬀect. To conclude, although acupuncture improved
menstrual mood symptoms in women with primary dysmenorrhea during the treatment phase, the trend in the improvement of
symptoms during the active phase of treatment, and at 6 and 12 months was non-signiﬁcant, indicating that a small treatment
eﬀect from acupuncture on dysmenorrhea may exist. In the study, acupuncture was acceptable and safe, but further appropriately
powered trials are needed before recommendations for clinical practice can be made.
1.Introduction
Primary dysmenorrhea refers to painful menstrual periods
in the absence of any underlying pathology. Dysmenorrhea
is a very common problem among young women, and can
occur in up to 50% of menstruating women [1]. There is
limited research reporting on the aﬀect of symptoms on
women’sdailylivingactivities,howeverstudiessuggestsevere
menstrual pain is associated with absence from school or
work and restricts other activities of daily life [2, 3].
There are three approaches to the management of
primary dysmenorrhea: pharmacological, non-pharmaco-
logical and surgical. Studies report simple analgesics are
commonly used by young women, with use of analgesics
reported by 52% of adolescents, and use of non-steroidal
anti-inﬂammatory drugs (NSAIDs) reported by 42% of
adolescents to alleviate their dysmenorrhea [4]. In a Swedish
study, 38% of women used analgesics and 22% used oral
contraceptives to alleviate their dysmenorrhea [5]. Evidence
of eﬃcacy supports use of pharmacological agents such as
NSAIDs [6], or the use of oral contraceptives [7]t oa l l e v i a t e
menstrual pain, however pain relief may be inadequate for
some women, or side eﬀects may not be well tolerated.
Women may use complementary medicines to alleviate
their dysmenorrhea, although precise ﬁgures describing the
frequency of use are not available. Data are limited on2 Evidence-Based Complementary and Alternative Medicine
patterns of use, but utilization data from the UK indicate
acupuncture is used to assist with the management of
gynecological or obstetric conditions by 8% of women [8].
Acupuncture has been used to treat dysmenorrhea, and
a summary of the evidence from randomized controlled
trials (RCTs) is given in two systematic reviews. A Cochrane
systematic review published in 2002 included one small
trial of acupuncture [9]. A total of 48 women from the
USA were allocated to one of four study groups: real
acupuncture, placebo acupuncture, standard control and
visitation control [10]. Nodiﬀerence in the mean pain scores
was found before, during (P<. 07) or after treatment
(P<. 06) between the study groups. Women in the
real acupuncture group showed an improvement in pain
relief compared with the placebo acupuncture group (odds
ratio (OR) 9.5, 95% conﬁdence interval (CI) 1.7–51.8), the
standard control group (OR 16.4, 95% CI 3.2–84.8) and
the visitation group (OR 22.0, 95% CI 2.12–117.1). The
Cochrane review concluded,“there was insuﬃcient evidence
to determine the eﬀectiveness of acupuncture in reducing
dysmenorrhea, and that further research was needed” [9].
A recent review included 30 RCTs of acupuncture-related
modalities [11].Total20 studiescompared acupuncturewith
a control group. Overall trials were of low methodological
quality. Nine trials suggested a beneﬁt from acupuncture,
however only two trials were of reasonable quality. One of
these trials was described earlier in the Cochrane review.
A second trial compared acupuncture with ibuprofen and
found that acupuncture was more eﬀective for pain relief
thanibuprofen(RR1.20,95%CI1.02to–1.42,P<. 03)[12].
Nine trials found no diﬀerences between groups. Following
publication of the recent systematic review, one large trial
of acupuncture conducted in Germany randomized 208
women with primary dysmenorrhea to acupuncture or a
control (wait list control) [13]. This trial found the intensity
of menstrual pain was lower in the acupuncture group
compared with the control (RR –2.9, 95% CI –2.9 to –1.6,
P<. 001), and improved quality of life on Short Form
36 (SF36) sub-scales at 3 months was signiﬁcantly more
pronounced in the acupuncture group compared with the
control. To summarize, evidence from one recent trial, and
two systematic reviews suggests acupuncture may reduce
dysmenorrhea. However, the poor methodological quality of
most trials suggests a need for further rigorous research.
The aim of our study was to examine the eﬀectiveness
of acupuncture in treating primary dysmenorrhea, and thus
contribute to the research base of accupunture eﬃcacy.
The primary hypotheses of this study were that the use of
acupuncture in women with dysmenorrhea compared with
control acupuncture would at 3, 6 and 12 months from
baseline be eﬀective at (i) reducing symptoms of dysmenor-
rhea as measured by: reduced severity and duration of pain,
reduced need for pain relief and an overall improvement
in menstrual symptoms, and (ii) improve quality of life, as
measured by improved health status indices, reduce time oﬀ
work or from school, less restriction on daily life activities
and less side eﬀects from treatment. We also examined the
acceptability and any adverse eﬀects associated with the use
of acupuncture.
2.Methods
Women were recruited for the study from the community
through their general practitioner, gynecologist or by adver-
tising inthemedia inSouthAustraliabetweenFebruary2003
and August2005. The Ethics Committee ofthe Women’sand
Children’s Hospital, Adelaide, South Australia, approved the
research, and all women gave informed written consent.
Women eligible to join the trial were aged 14–25 years
with a diagnosis of primary dysmenorrhea. Our criteria for
establishing a diagnosis of primary dysmenorrhea was based
on self-reported severe incapacitating pain for at least one
day of menses in two menstrual cycles classiﬁed by a pre-
deﬁned pain score of ≥6/10 on the short form of the McGill
questionnaire and a visual analog scale [14], and pain that
did not respond well to analgesics. To exclude a diagnosis
of secondary dysmenorrhea, women needed to present with
evidence of a clinical examination conﬁrming a diagnosis
of primary dysmenorrhea, or to attend for an appointment
with the study gynecologist. The entry criteria adopted for
this trial were based on the inclusion criteria used in the
Cochrane systematic review [9]. Women were not eligible
if they had secondary dysmenorrhea (deﬁned as identiﬁable
pelvic pathology), or dysmenorrhea associated with an
intrauterine device. Women were allowed to continue taking
oralcontraceptivesorpharmacologicalpainreliefifrequired.
A computer-generated randomization schedule was cre-
ated using variable block size and stratiﬁed by previous use
or non-use of acupuncture. The randomization schedule
was computer generated by an independent statistician. The
allocation of the randomization sequence was concealed
centrally by telephone. The telephone randomization service
was available7daysaweek atTheUniversityofAdelaide,and
allocationwasmadetooneoftwostudygroups,acupuncture
or control. The randomized treatment allocation was known
only to the acupuncturist administering the study interven-
tion.
Three acupuncturists registered with the Australian
Acupuncture and Chinese Medicine Association admin-
istered the acupuncture to the study groups. Subjects
underwent a traditional Chinese medicine (TCM) diagnosis
to identify the TCM pattern causing dysmenorrhea. All
women received their allocated treatment administered for
30–40min, weekly for 3 weeks, followed by a week of no
treatment during the week of expected menses, for three
menstrual cycles. At the end of the treatment phase all
women were followed up over a further 3 and 12 months
during which no further study treatment was administered.
Womenwere mailed follow-upquestionnairestotheirhome,
and the trial co-ordinator telephoned women to encourage
response to the follow-up questionnaires.
The design oftheacupuncture intervention,and the acu-
puncture points were based on expert opinion [15], a review
oftheresearch undertakenand theexperience oftheresearch
practitioners. Women in the acupuncture group received
acupuncture to treat their underlying TCM diagnosis. The
most common diagnoses arising for dysmenorrhea are:
stagnation of Qi and blood, stagnation of cold, damp heat
attacking the lower jiao, deﬁciency of Qi and blood andEvidence-Based Complementary and Alternative Medicine 3
deﬁciency of kidney and liver. Nine diagnostic patterns
with standardized treatment regimens were documented
in a treatment protocol. Moxibustion was not adminis-
tered because of the diﬃculty of blinding subjects. Seirin
0.2×30 mm acupuncture needles were inserted bilaterally
to a depth of ≤2cm, and the needles were retained for
30min. All subjects received the de qi sensation (which is
the needling sensation of soreness, numbness or heaviness)
following initial insertion of needles and half way through
the treatment session. Reinforcing or reducing stimulation
was givenaccording to the TCM diagnoses, and standardized
to the individual. Primary acupuncture points include
GongSun SP4, Guilai ST29, Zhongji Ren-3, Ciliao BL32, Diji
SP8, Sanyinjiao SP6 and additional points used according to
the individual diagnoses. A minimum of seven points were
used at each treatment. For example,
(i) Qi and blood stagnation: Taichong LR3, Sanyinjiao
SP6, Hegu LI4, Zhongji Ren-3, Ciliao UB32, Xuehai
SP10, Qihai Ren-6, Diji SP8, GongSun SP4.
(ii) Qi and blood deﬁciency: Zusanli ST36, Sanyinjiao
SP6, Guanyuan Ren-34, Qihai Ren-6, Geshu BL17,
Diji SP8, Pishu UB20, Ciliao UB32.
(iii) Stagnation of cold: Shenshu UB23, Zhongji Ren-3,
Qihai Ren-6, Sanyinjiao SP6, Guanyuan Ren-4,
Mingmen Du-4, Lie Que LU7, Zhaohai KD6, Zusanli
ST36.
(iv) Accumulation of damp heat: Yanglingquan GB34,
Quchi LI11, Xingjian LR2, Guilai ST29, Ciliao UB32,
Fenglong ST40, Yinlingquan SP9, Shuidao ST28,
Sanyinjiao SP6, Sanjiaoshu UB22.
(v) Kidney and Liver deﬁciency: Zusanli ST36, Sany-
injiao SP6, Guanyuan Ren-4, Qihai Ren-6, Geshu
UB17, Ganshu UB18, Shenshu UB23, Taixi KD3.
The control group received sham acupuncture, with the
timing and duration of the control intervention the same
as the active acupuncture group. Sham points were not
acupuncture points, and the placebo needle was inserted
away from classical acupuncture points and meridians on
the sacral area, lower back, lower abdomen, foot, lower
leg and forearm. These locations ranged 2–4cm away from
an acupuncture point or meridian. Ashi points were not
used. Placebo acupuncture needles (0.30×30 mm) were
used [16]. As the tip of the placebo needle is blunted,
skin penetration does not occur. Needles were manually
“stimulated”byliftingandthrustingthehandleoftheneedle.
Seven bilateral sham points were used.
Primary and secondary endpoints were measured at 3,
6 and 12 months after trial entry. The primary outcome
measures speciﬁed ap r i o r i , were menstrual pain intensity
and duration measured by the McGill questionnaire [14].
The overall improvement in dysmenorrhea (measured by
change in dysmenorrhea symptoms, e.g., nausea, vomiting
and mood changes), and the proportion of women requiring
additional analgesia for pain relief were gathered by a
self-report questionnaire completed by subjects. Subjects
completed a self-report questionnaire to collect data on
secondary endpoints including restriction with daily living
activities, and the SF36 [17]. Data on the acceptability of
the treatment intervention, assessment of blinding and the
credibility of the intervention were made at the end of the
study period [18].
A power analysis showed that a sample size of 92 women
would detect a diﬀerence in pain reduction of 29%, from 69
to 40% between treatment groups (P<. 05, 80% power). To
detect a change in the SF36 quality-of-life score of 17.7 units
from baseline between treatment groups with 80% power at
the 5% signiﬁcance level assuming the standard deviation in
SF36 scores was 30, the sample size was 92. We anticipated
loss to follow-up would be kept to <15%.
The analyses were carried out by an independent statis-
tician (H.D.) using SAS software, Version 9.2 [19]. The
analyses used an “intention to treat” approach. Diﬀerences
in the primary study outcome measures between the two
groupswere analyzed using mixed model analysisofvariance
with subject as a random eﬀect for continuous, normally
distributed variables and generalized estimating equations
for categoricalvariables. Adjustments for imbalance between
the two treatment-groups were made for body mass index
(BMI), smoking and socio-economic status. Diﬀerences in
secondary outcomemeasures wereanalyzed using chi-square
or Fisher’s exact tests, as appropriate, with log-binomial
regression used to adjust for imbalances. A P-value of
<.05 was considered to indicate statistical signiﬁcance (two-
sided).
Clinical Trial Registration: Australian New Zealand
Clinical Trials Registry, http://www.anzctr.org.au/ ACTRN
12605000766617.
3.Results
3.1. Trial Recruitment and Subject Flow. Enquiries about
the trial were made by 330 women, although just over
half (170, 52%) did not meet the criteria for a diagnosis
of primary dysmenorrhea based on the pre-speciﬁed pain
score—one had an IUD, 8 were diagnosed with secondary
dysmenorrhea, 37 did not meet the age criteria and 22
withdrew their interest in the study (Figure 1).
Atotalof92women were randomlyassigned totheinter-
vention, with all 46 women in each group included in the
analysis. At 3 months data were available from 92% of sub-
jects (acupuncture 89%, control 96%), at 6 months 83% of
subjects (acupuncture 80%, control 85%) and at 12 months
91% of subjects (both treatment groups 91%). Two women
in the control group were lost to follow-up at 12 months.
3.2. Background Characteristics. Most subjects were Cau-
casians (92%), single (92%) and 57% were students. The
median (inter quartile range (IQR)) number of treatments
actually received was nine [6–9] for acupuncture and nine
[8, 9] for the control group. The randomized groups were
comparable for most baseline characteristics at trial entry
(Table 1). There was a >5% diﬀerence in BMI, smoking
and socio-economic indexes for areas (SEIFA) [20]s c o r e s
and primary outcomes were adjusted for BMI, smoking and
SEIFA score in the analyses.4 Evidence-Based Complementary and Alternative Medicine
Table 1: Characteristics of the women at trial entry by allocated treatment group.
Acupuncture group, n = 46 Control group, n = 46
Age in yearsa 19.5 (2.9) 18.9 (3.2)
BMI
Underweight 4 (8.7) 3 (6.5)
Normal (18.5 to <25) 29 (63.0) 26 (56.5)
Overweight (25 to <30) 6 (13.0) 9 (19.6)
Obese (≥30) 2 (4.3) 4 (8.7)
Missing 5 (10.9) 4 (8.7)
Currently smoking 5 (10.9) 2 (4.3)
Ever alcohol drinking 29 (63.0) 33 (71.7)
Finished high school 10 (21.7) 12 (26.1)
Completed tertiary education 14 (30.4) 13 (28.3)
SEIFA
Low SEI 14 (30.4) 8 (17.4)
High SEI 15 (32.6) 21 (45.7)
Menstrual pain intensity 5.6 (3.1) 6.1 (2.5)
Other menstrual symptoms 46 (100.0) 44 (95.7)
Need for additional analgesia 43 (93.5) 41 (89.1)
Restricted activities 24 (52.2) 20 (43.5)
SF36
Physical functioningb 95 (70–100.0) 95 (90–100)
Role physicalb 100 (75–100) 100 (50–100)
Bodily pain 53.8 (20.6) 55.4 (18.7)
General health 68.8 (17.5) 67.7 (21.2)
Vitality 53.7 (20.5) 55.7 (16.3)
Social functioning 75.3 (20.9) 77.2 (19.5)
Role emotional 74.1 (36.9) 75.6 (34.4)
Mental health 63.5 (21.7) 69.4 (14.8)
Overall Physical Component (SF36) 49.0 (8.6) 49.3 (6.8)
Overall Mental component 43.9 (13.1) 45.3 (9.8)
Brazier Health State Utility 0.7 (0.1) 0.81 (0.1)
Values are number (%) of women.
aValues are mean (SD), or median (IQR).
bSEIFA, a measure of the socio-economic well-being of Australian communities,and identify areas of advantage and disadvantage [19].
3.3. Primary Outcomes. Unadjusted and adjusted analyses
are reported for primary outcomes (Table 2). At the end of
the 3 months treatment phase although the pain outcomes
were marginally lower for women in acupuncture group,
there were no signiﬁcant diﬀerences between groups
(Figure 2). Women reported fewer mood changes in the
acupuncture group (53%) compared with the control
group (72%), 0.72, 95% CI 0.53–1.00, P = .05, (Figure 3).
Six months following trial entry, there was a signiﬁcant
reduction in the duration of menstrual pain in the
acupuncture group (30h) compared with the control group
(39h), P = .04, and a reduced need for additional analgesia
in the acupuncture (54%) compared with the control group
(82%), 0.69, 95% CI 0.49–0.96, P = .03. The intensity of
pain was lower for women receiving acupuncture, but not
signiﬁcantly diﬀerent to the control group. At the 12-month
follow-up, the earlier improvements reported by women
in the acupuncture group were no longer sustained, and
there were no diﬀerences between groups. The intensity of
menstrual pain, duration of pain and the presence of other
menstrual symptoms (Figure 4) reduced overtime from trial
entry for both groups.
3.4. Secondary Outcomes. There was no signiﬁcant improve-
ment in quality of life between the two treatment groups at
any time point (Table 3). There were no diﬀerences between
groups in relation to restriction on daily living activities.
Subjects were asked to report any side eﬀect or beneﬁcial
eﬀects they attributed to “the study intervention” (e.g.,
dizziness, tiredness, feeling energized, bruising, nausea) at
theendofeachmonth.Reportingofsideeﬀectsorsymptoms
did not diﬀer between groups. The most frequently reported
beneﬁcial eﬀects were feeling relaxed (29%), calm and
peaceful (23%). The experience and reporting of any “eﬀect”Evidence-Based Complementary and Alternative Medicine 5
Assessed for eligibility
n = 330
Randomized
women who agreed to take
part in the trial
n = 92
Not randomized n = 238
Withdrew interest n = 22
Did not meet age criteria n = 37
Secondary dysmenorrhea n = 8
IUD n = 1
Did not meet diagnosis for primary
dysmenorrhea n = 170
Allocated to acupuncture
n = 46
Allocated to control
n = 46
Lost to follow up at 12months
n = 0
Lost to follow up at 12months
n = 2
Analyzed
3months n = 41, 89.1%
6months n = 37, 80%
12months n = 42, 91.3%
Analyzed
3months n = 44, 95.6%
6months n = 39, 85%
12months n = 42, 91.3%
Figure 1: Recruitment and ﬂow of subjects through trial.
washighestintheﬁrst monthoftreatment (60%ofsubjects),
and declined over the subsequent 2 months. There were no
serious adverse eﬀects reported.
3.5. Assessment of Blinding. To assess whether subjects
remained blind to their group allocation, women were
asked at the end of the third month of the study which
group they thought they were allocated to. A total of 41%
women receiving acupuncture believed they had received
true acupuncture, and 22% of women in the control group
thought they were receiving true acupuncture (P = .07), 34
and 42%, respectively, were unsure of their group allocation
(P = .43). Participants’ reason for their perceived group
allocationweremostlysimilarbetweengroups,exceptfor7%
of women in the acupuncture group and 29% of women in
the control group reporting no improvement (P = .01). The
trialresultsindicatethat,irrespectiveoftheirallocatedgroup,
participants liked being in the trial (Table 4). Women liked
assisting with the research, the contact with project staﬀ and
theattentiontotheirhealth.Asmallnumberofwomeninthe
treatment group (n = 5, 10%) disliked being in the trial due
to the discomfort from needling. There were no diﬀerences
in responses between groups.
4.Discussion
This study found insuﬃcient evidence that acupuncture
administered over a 3-month period provided eﬀective relief6 Evidence-Based Complementary and Alternative Medicine
Table 2: Primary study outcomes by treatment group.
Menstrual outcomes Acupuncture
group, n = 46
Control group,
n = 46
Unadjusted treatment
eﬀect (95% CI)
Unadjusted
P-value
Adjusted treatment
eﬀect (95% CI)
Adjusted
P-value
3m o n t h s
Pain intensitya
Day 1 4.9 (3.2) 4.9 (2.8) −0.1 (−1.2 to 1.0) .90 −0.2 (−1.3 to 0.9) .68
Day 2 3.5 (3.0) 4.0 (2.8) −0.6 (−1.7 to 0.5) .28 −0.8 (−1.9 to 0.3) .17
Day 3 2.0 (2.5) 2.6 (2.7) −0.6 (−1.7 to 0.5) .32 −0.7 (−1.8 to 0.4) .21
Other menstrual symptoms 32 (78.0) 36 (81.8) 0.93 (0.76, 1.15) .53 0.93 (0.75 to 1.15) .49
Duration of pain (hours)a 31.5 (24.8) 32.9 (19.9) −1.6 (−10.4 to 7.2) .72 −2.5 (−11.3 to 6.4) .59
Need for additional analgesia 26 (63.4) 27 (61.4) 1.01 (0.73 to 1.40) .96 1.05 (0.76 to 1.44) .77
6m o n t h s
Pain intensitya
Day 1 4.9 (3.0) 5.0 (2.5) −0.3 (−1.4 to 0.9) .67 −0.4 (−1.6 to 0.7) .47
Day 2 3.8 (3.1) 4.6 (2.7) −0.9 (−2.1 to 0.2) .11 −1.1 (−2.3 to 0.0) .06
Day 3 2.2 (3.0) 2.8 (2.7) −0.7 (−1.9 to 0.4) .20 −0.9 (−2.1 to 0.2) .11
Other menstrual symptoms 28 (75.7) 32 (82.1) 0.93 (0.74 to 1.17) .53 0.92 (0.74 to 1.15) .48
Duration of pain (hours)a 30.7 (20.9) 39.2 (18.2) −8.5 (−17.7 to 0.7) .07 −9.6 (−18.9 to –0.3) .04
Need for additional analgesia 20 (54.1) 32 (82.1) 0.66 (0.47 to 0.92) .01 0.69 (0.49 to 0.96) .03
12 months
Pain intensitya
Day 1 5.4 (2.7) 4.6 (2.5) 0.8 (−0.3 to 1.9) .18 0.6 (−0.5 to 1.7) .29
Day 2 4.8 (2.9) 4.0 (2.4) 0.7 (−0.4 to 1.8) .20 0.5 (−0.6 to 1.6) .33
Day 3 2.6 (2.7) 2.8 (2.4) −0.1 (−1.2 to 1.0) .81 −0.3 (−1.4 to 0.8) .60
Other menstrual symptoms 34 (81.0) 40 (95.2) 0.87 (0.75 to 1.02) .08 0.87 (0.74 to 1.02) .08
Duration of pain (hours)a 38.3 (21.3) 38.2 (21.3) −1.1 (−9.9 to 7.7) .81 −2.3 (−11.2 to 6.6) .62
Need for additional analgesia 34 (81.0) 30 (71.4) 1.13 (0.89 to 1.44) .31 1.17 (0.92 to 1.47) .19
Values are number (%) of women.
aValues are mean (SD).
0
6
12
18
24
30
36
42
48
H
o
u
r
s
Time (months)
Acupuncture
Control
0123 6 1 2
Figure 2: Mean duration of pain (hours).
frommenstrual painforwomenwithprimary dysmenorrhea
compared with the control group. Our ﬁndings do however
suggest that acupuncture improved women’s mood symp-
toms during the treatment phase of the study. Our ﬁndings
show a non-signiﬁcant trend in the improvement of men-
strual symptoms during the active phase of treatment, and
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Figure 3: Percentage of women experiencing mood changes.
at 6 and 12 months. Evidence of beneﬁt from acupuncture
was found in the follow-up period, with a reduction in the
duration of pain and less need for pain relief. We used a
credible control with subjects unable to identify their group
allocation, and our results demonstrate that acupuncture
was a safe and acceptable treatment for women. The resultsEvidence-Based Complementary and Alternative Medicine 7
Table 3: Quality-of-life outcomes by treatment group.
Quality-of-life outcome Acupuncture
group, n = 46
Control
group, n = 46
Unadjusted treatment
eﬀect (95% CI)
Unadjusted
P-value
Adjusted treatment
eﬀect (95% CI)
Adjusted
P-value
3 months (SF36)
Physical functiona 95.0 (90.0−100) 95.0 (90.0−100) .58 .58
Role physicala 100 (50−100) 100 (75.0−100) .81 .96
Bodily painb 64.4 (23.7) 71.9 (21.3) −6.7 (−15.8 to 2.3) .14 −6.1 (−15.1 to 2.8) .18
General healthb 69.2 (20.5) 66.9 (24.7) 3.2 (−5.8 to 12.1) .49 5.1 (−3.0 to 13.2) .22
Vitalityb 55.8 (21.8) 53.6 (23.1) 1.9 (−6.5 to 10.3) .66 3.2 (−5.1 to 11.6) .44
Social functionb 78.8 (22.3) 79.3 (21.9) −0.2 (−9.4 to 8.9) .96 1.1 (−8.0 to 10.3) .81
Role emotionalb 75.0 (36.0) 75.0 (33.0) 0.2 (−15.2 to 15.6) .98 2.2 (−12.7 to 17.1) .77
Mental healthb 71.4 (18.2) 67.0 (20.8) 4.5 (−3.3 to 12.2) .26 6.0 (−1.7 to 13.6) .13
Overall Physical Componentb 49.6 (9.1) 52.5 (7.6) −2.7 (−6.3 to 0.9) .14 −2.3 (−5.9 to 1.2) .19
Overall Mental Componentb 46.1 (10.3) 43.6 (11.8) 2.6 (−2.0 to 7.3) .26 3.5 (−1.1 to 8.1) .14
Brazier Health State Utilityb 0.75 (0.13) 0.75 (0.12) 0.0 (−0.05 to 0.05) .95 0.0 (−0.04 to 0.05) .86
Restricted activities 11 (26.8) 14 (31.8) 0.86 (0.44 to 1.68) .66 0.8 (0.45 to 1.72) .71
6 months (SF36)
Physical functiona 95.0 (85.0−100) 95.0 (90.0−100) .96 .94
Role physicala 87.5 (50−100) 100 (75.0−100) .41 .62
Bodily painb 69.1 (23.6) 68.3 (21.3) 1.7 (−7.5 to 10.9) .71 2.5 (−6.7 to 11.6) .60
General healthb 69.2 (19.5) 66.3 (25.5) 2.5 (−6.5 to 11.5) .58 4.5 (−3.7 to 12.7) .28
Vitalityb 53.5 (19.8) 56.8 (19.6) −2.8 (−11.3 to 5.8) .53 −1.3 (−9.8 to 7.1) .76
Social functionb 73.1 (25.4) 80.6 (21.4) −6.6 (−15.9 to 2.7) .16 −5.0 (−14.3 to 4.3) .29
Role emotionalb 64.6 (38.5) 80.8 (29.1) −13.8 (−29.4 to 1.8) .08 −11.3 (−26.5 to 3.8) .14
Mental healthb 65.3 (19.2) 72.0 (15.6) −6.1 (−14.0 to 1.8) .13 −4.5 (−12.2 to 3.3) .26
Overall Physical Componentb 51.5 (9.0) 51.0 (8.6) 1.3 (−2.4 to 4.9) .50 1.6 (−2.0 to 5.2) .38
Overall Mental Componentb 42.4 (11.2) 46.3 (9.8) −3.9 (−8.6 to 0.8) .11 −3.0 (−7.6 to 1.7) .21
Brazier Health State Utilityb 0.74 (0.10) 0.78 (0.10) −0.04 (−0.09 to 0.01) .11 −0.04 (−0.8 to 0.01) .14
Restricted activities 7 (18.9) 15 (38.5) 0.51 (0.23 to 1.10) .08 0.50 (0.23 to 1.08) .08
12 months (SF36)
Physical functiona 95.0 (90.0−100) 100 (90.0−100) .57 .58
Role physicala 100 (50.0−100) 100 (50.0−100) .71 .95
Bodily painb 68.0 (20.7) 73.4 (22.5) −4.0 (−13.1 to 5.0) .38 −3.4 (−12.4 to 5.6) .46
General healthb 67.6 (19.5) 69.8 (24.0) −2.8 (−11.7 to 6.1) .54 −0.9 (−9.0 to 7.3) .83
Vitalityb 55.0 (17.7) 56.7 (21.7) −1.7 (−10.1 to 6.8) .70 −0.4 (−8.8 to 7.9) .92
Social functionb 79.9 (21.8) 81.0 (20.9) −0.7 (−9.8 to 8.4) .88 0.7 (−8.4 to 9.8) .88
Role emotionalb 69.1 (40.4) 73.0 (35.5) −5.2 (−20.7 to 10.4) .51 −2.8 (−17.8 to 12.3) .72
Mental healthb 68.5 (15.8) 71.8 (14.2) −3.3 (−11.1 to 4.5) .41 −1.8 (−9.4 to 5.9) .65
Overall Physical Componentb 51.4 (6.8) 51.7 (10.0) 0.3 (−3.3 to 3.9) .88 0.6 (−2.9 to 4.2) .73
Overall Mental Componentb 44.4 (10.6) 45.5 (8.9) −1.8 (−6.5 to 2.9) .44 −1.0 (−5.7 to 3.6) .67
Brazier Health State Utilityb 0.76 (0.10) 0.77 (0.11) −0.01 (0.06 to 0.03) .62 −0.01 (−0.06 to 0.04) .72
Restricted activities 19 (45.2) 13 (31.0) 1.46 (0.82 to 2.61) .20 1.42 (0.83 to 2.44) .20
Values are number (%) of women.
aValues are median (IQR).
bValues are mean (SD).
suggest that a small treatment eﬀect cannot be excluded, and
our study may have been under powered.
Our trial contributes to a body of methodologically rig-
orous trials of acupuncture to treat dysmenorrhea. Although
the evidence from RCTs is encouraging but limited by a
small body of high-quality RCTs, evidence of a beneﬁt
from acupuncture from uncontrolled study designs grows.
A recent observational study found a substantial reduction
in pain and the use of NSAIDs by 87% of women, and con-
cluded acupuncture may have a role with the management
of dysmenorrhea for women for whom oral contraceptives
or NSAIDs are contra-indicated [21]. Other modalities of8 Evidence-Based Complementary and Alternative Medicine
Table 4: Secondary study outcomes by allocated treatment group.
Acupuncture
group, n = 46
Control
group, n = 46
Unadjusted
treatment eﬀect
(95% CI)
Unadjusted
P-value
Adjusted treatment
eﬀect (95% CI)
Adjusted
P-value
What I liked
I was reassured by the extra
attention to my health 22 (47.8) 20 (43.5) 1.10 (0.70–1.72) .68 1.09 (0.71–1.67) .70
Few extra demands on my time 4 (8.7) 6 (13.0) 0.67 (0.20–2.21) .50 —
My contact with project staﬀ 24 (52.2) 21 (45.7) 1.14 (0.75–1.74) .53 1.22 (0.81–1.83) .34
Assisting with research to help
others like me 37 (80.4) 33 (71.7) 1.12 (0.89–1.41) .33 1.12 (0.90–1.39) .32
There was nothing I liked 0 (0) 1 (2.2) 1.25 (0.36–4.36) 1.0 1.30 (0.36–4.64) .69
Other 5 (10.9) 4 (8.7) .73
What I disliked
I felt more anxious about my
health 1 (2.2) 0 (0.0) 1.00 —
Extra demands on my time 6 (13.0) 6 (13.0) 1.00 (0.35–2.87) 1.00 —
My contact with project staﬀ 0 (0.0) 0 (0.0) —
Being randomized meant I had no
say in the decision to have
acupuncture
3 (6.5) 3 (6.5) 1.00 (0.21–4.70) 1.00 —
There was nothing I disliked 32 (69.6) 36 (78.3) 0.89 (0.70–1.13) .34 0.95 (0.75–1.21) .67
Other 5 (10.9) 0 (0.0) .06
Would you agree to participate in the
research study again?
Deﬁnitely yes 31 (70.5) 34 (75.6) 0.91 (0.70–1.19) .49 0.98 (0.75–1.29) .56
Probably yes 7 (15.9) 9 (20.0) 0.78 (0.32–1.91) .58 0.74 (0.27–2.03) .90
I’m not sure 3 (6.8) 1 (2.2) 3.00 (0.32–27.79) .33
Probably not 2 (4.5) 1 (2.2) 2.00 (0.19–21.30) .57
Deﬁnitely not 1 (2.3) 0 (0.0)
Values are number (%) of women.
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Figure 4: Percentage of women experiencing other menstrual
symptoms.
acupuncture may also be eﬀective with the management of
dysmenorrhea. Asmall pilot study ofacupuncturecombined
with spinal tuina was compared with acupuncture alone
[22]. Following 3 months of treatment acupuncture plus
tuina appeared more eﬀective than acupuncture alone (93
versus 73%). Zhao reports on a case series of auricular
acupuncture, acupoint injection, moxibustion therapy and
cupping, all of which suggest a beneﬁt and highlight further
areas for research [23].
Pain is complex, and a highly individualized experience,
that is diﬃcultto assess, examine, manage and treat.Figure 5
illustrates a potential mechanism of acupuncture for the
treatment of dysmenorrhea and symptoms relating to our
study ﬁndings. Pomeranz proposed that acupuncture stim-
ulation activated A-δ and C aﬀerent ﬁbers in muscle [24].
During needle stimulation of acupuncture points such as
SP6, SP8and Ren 4signals are transmitted tothe spinal cord,
and via aﬀerent pathways to the midbrain. The perception
of pain emerges from the resulting ﬂow and integration
of this information among speciﬁc brain areas and leads
to a change in the perception of pain. The descending
pain-modulatory system is a key anatomical network that
underlies the ability to change pain intensity [25]. We pro-
posed the brainstem structures involved in the descending
modulation alter women’s perception of pain resulting fromEvidence-Based Complementary and Alternative Medicine 9
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Figure 5: Hypothesized mechanism of acupuncture on dysmenorrhea and related symptoms.
dysmenorrhea. Prostaglandin F2α (PGF2α)i sr e s p o n s i b l e
for dysmenorrhea. Symptoms associated with menstrual
pain such as headache, nausea and vomiting, backache and
diarrhea can be explained by entry of prostaglandins and
prostaglandin metabolites into systemic circulation. The
associated improvement in dysmenorrhea-related symptoms
we propose are inﬂuenced by a subsequent mechanism
arising from a release of neurotransmitters in relation to
the integration of information from the neural pathways
in response to needle stimulation. When these signals
reach the hypothalamus and pituitary they trigger a neuro-
endocrine response. In an animal model stimulation of10 Evidence-Based Complementary and Alternative Medicine
acupuncture points CV4, SP6, SP8 have beenshown to regu-
late neuro-endocrine activities including follicle stimulating
hormone, luteinizing hormone, estradiol and progesterone
[26].
Our trial has several strengths. The risk of bias in the trial
was minimal, with central randomization, credibility assess-
ment and high compliance with the treatment protocol. We
had a low attrition rate at the 6- and 12-month follow-up,
and there was no diﬀerence in the attrition rate between
groups. Overall, the potential for unblinding was low, with
women blinded to their group allocation. We consider
our acupuncture treatment protocol was representative of
what many acupuncture practitioners would administer in
practice in relation to selection of acupuncture points,
frequency of treatment and the time of needle stimulation,
and the treatment protocol was viewed as acceptable by the
majority of participants.
The limitations of the trial reﬂect the lack of power, and
whether the results can be representative of women with
primary dysmenorrhea. Just >50% of women interested in
the study did not meet the inclusion criteria relating to
the diagnosis of primary dysmenorrhea based on a self-
assessment of menstrual pain. Our results however apply
to a smaller group of women with more severe menstrual
symptoms. Consideration must also be given to the possibil-
ity that the control group was ‘active’. Lund and Lundeberg
propose the use of acupuncture controls that involve light
touch of the skin such as the placebo needle may stimulate
mechanoreceptorsthatresultin thealleviation oftheaﬀerent
component of pain [27]. This proposition may explain why
control interventions are equally eﬀective as acupuncture in
alleviating some pain-related conditions [27]. An alternative
explanation of the lack of eﬀectiveness of acupuncture in
our study at 3 months could attribute the ﬁndings to
an “inadequate” acupuncture intervention. The treatment
protocol used in the eﬀective RCT by Witt [13], delivered
the acupuncture intervention over 15 acupuncture sessions
(mean number received 10.5±3.1 acupuncture sessions),
with practitioners selecting the most appropriate treatment
fortheindividual.Althoughourtrialwasshorterinduration,
the Witt trial delivered only one additional treatment. The
pain outcome measures used in our RCT and the Witt trial
used diﬀerent scales, yet the actual menstrual pain scores at
3 and 6 months appear similar. We suggest the acupuncture
intervention in our trial may have been adequate in the main
respects including duration, but the lack of eﬀect reﬂects a
lack of power.
It was interesting to observe the optimal eﬀects of
acupuncture were experienced 3 months after the study
intervention ceased. This observation was also reported in
t h eW i t tt r i a l ,a n dm a yb ei m p o r t a n tf o rt h ed e s i g no f
future trials. The ﬁnding is diﬃcult to explain from a
TCM perspective. The lack of any treatment eﬀect at 12
months following nine treatments was not surprising. In
practice, many acupuncture practitioners would administer
a tapered schedule of maintenance acupuncture treatments
following evidence of a treatment eﬀect. The observation
that both groups experienced signiﬁcant improvements over
time lends further support to the overall therapeutic eﬀect
of acupuncture comprising in part of non-needling eﬀects
beneﬁting both groups of subjects. The observation of
beneﬁt at follow-up warrants further exploration.
Recentresearch ofacupuncturetotreatlowbackpainhas
found that tailored individualized acupuncture treatments
oﬀer no additional beneﬁt over standardized and stimulated
acupuncture [28]. The relevance of these ﬁndings for
acupuncture to treat period pain is unclear, and future
research may wish to consider use of both acupuncture
individualized, standardized groups in addition to control
groups.
Acupuncture was an acceptable and safe treatment,
although we found no consistent evidence of beneﬁt
from acupuncture. Acupuncture may improve women’s
mood symptoms but further appropriately powered trials
are needed to examine the eﬀect on reducing menstrual
pain.
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